These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6021455)

  • 21. [Studies on changes in blood coagulation during and after operations with the help of the heart lung machine (author's transl)].
    Köstering H; Kirchhoff PG; Völker P; Warmann E; Koncz J
    Thoraxchir Vask Chir; 1973 Dec; 21(6):534-43. PubMed ID: 4544868
    [No Abstract]   [Full Text] [Related]  

  • 22. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 23. Misleading heparin monitoring leading to protamine sulphate in patient with lupus anticoagulant.
    Wanger GP; Roberts W; Brandt J
    Lancet; 1981 Nov; 2(8255):1112. PubMed ID: 6118557
    [No Abstract]   [Full Text] [Related]  

  • 24. Is protamine a clinically important anticoagulant? A negative answer.
    Ellison N; Ominsky AJ; Wollman H
    Anesthesiology; 1971 Dec; 35(6):621-9. PubMed ID: 5124742
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of DIC after open heart surgery associated with heparin neutralization.
    Popov-Cenić S; Müller N; Kladetzky RG
    Bibl Anat; 1975; 13():293-4. PubMed ID: 1231759
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood coagulation studies and extracorporeal circulation in man.
    Thurnherr N
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
    [No Abstract]   [Full Text] [Related]  

  • 27. Coagulation defects during extracorporeal circulation in the dog.
    Alvarez L; Escudero C; Rodríguez V; Ortiz J; Castillo-Olivares JL
    Eur Surg Res; 1987; 19(2):118-23. PubMed ID: 3816887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bypass surgery on coagulation-sensitive clotting factors.
    Woods JE; Kirklin JW; Owen CA; Thompson JH; Taswell HF
    Mayo Clin Proc; 1967 Nov; 42(11):724-35. PubMed ID: 6053800
    [No Abstract]   [Full Text] [Related]  

  • 29. [The problem of blood coagulation in patients with congenital heart diseases submitted to open heart surgery. Neutralization of heparin following extracorporeal circulation].
    Ricucci G; Lazzari A; Roncalli MG; Zanardi R; Funiciello AM; Gatti G
    Minerva Cardioangiol; 1977 Feb; 25(2):173-84. PubMed ID: 854178
    [No Abstract]   [Full Text] [Related]  

  • 30. [APROPOS OF HEPARIN NEUTRALIZATION AFTER EXTRACORPOREAL CIRCULATION. THE "IN VIVO" PROTAMINE TEST. PRELIMINARY NOTE].
    MONTIES JR; BELLAIS M
    Mars Chir; 1963; 15():468-70. PubMed ID: 14118186
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathogenesis, prophylaxis and therapy of hemostatic disorders in congenital cardiopathies].
    Perlick E; Ursinus K; Ursinus W; Hofmann G
    Z Gesamte Inn Med; 1971 Sep; 26(17):545-51. PubMed ID: 5125158
    [No Abstract]   [Full Text] [Related]  

  • 32. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.
    Sørensen B; Asvaldsdottir HS; Gudmundsdottir BR; Onundarson PT
    Thromb Res; 2009 Dec; 124(6):695-700. PubMed ID: 19733387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of hemorrhage following cardiopulmonary bypass.
    Verska JJ
    Ann Thorac Surg; 1972 Jan; 13(1):87-8. PubMed ID: 4257778
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization.
    Moriau M; Masure R; Hurlet A; Debeys C; Chalant C; Ponlot R; Jaumain P; Servaye-Kestens Y; Ravaux A; Louis A; Goenen M
    Vox Sang; 1977; 32(1):41-51. PubMed ID: 841962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 37. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of two schemes of administering the Russian protamine sulfate after extracorporeal circulation in cardiosurgical patients].
    Charnaia MA; Morozov IuA; Gladysheva VG; Isaeva AM
    Anesteziol Reanimatol; 2006; (5):31-3. PubMed ID: 17184058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROBLEMS IN HEMOSTASIS WITH EXTRACORPOREAL APPARATUS.
    GIBBON JH; CAMISHION RC
    Ann N Y Acad Sci; 1964 Jul; 115():195-8. PubMed ID: 14192824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.